08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
We’ve noted many times that while employees prevail on most motions for conditional certification u...
Read More >
Can a foreign individual without an Individual Taxpayer Identification Number (“ITIN”) serve as th...
Read More >
The SECURE Act—the most impactful retirement plan legislation since the Pension Protection Act of 2...
Read More >
With the arrival of 2019 novel coronavirus (“COVID-19”) to the United States, employers should beg...
Read More >
Case Law Developments - Place of supply for VAT purposes - The recent case of American Express S...
Read More >
I once had a law school professor who joked that we change the bankruptcy laws to give business to b...
Read More >